4.7 Article

Development of QTMP: A promising anticancer agent through NP-Privileged Motif-Driven structural modulation

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Biochemistry & Molecular Biology

3,5-bis(styryl)pyrazole inhibits mitosis and induces cell death independent of BubR1 and p53 levels by depolymerizing microtubules

Pooja J. Batra et al.

Summary: In this study, it was found that 3,5-bis[(1E)-2-(2,6-dichlorophenyl)ethenyl]-1H-pyrazole 2l depolymerizes microtubules and reduces their growing tips. Pyrazole 2l treatment inhibits chromosome movements, activates the spindle assembly checkpoint, and blocks mitosis in MCF-7 cells. Furthermore, it induces cell death through various pathways and exhibits stronger antiproliferative effects in cancerous cells compared to non-cancerous cells.

JOURNAL OF BIOCHEMISTRY (2023)

Review Chemistry, Multidisciplinary

Chemical Evolution of Natural Product Structure

Michael Grigalunas et al.

Summary: This article introduces the concept, design, and development workflow of pseudo-natural products, and discusses their relationship with natural products and cheminformatic analysis.

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2022)

Article Biochemistry & Molecular Biology

Microtubule-targeting agents impair kinesin-2-dependent nuclear transport of β-catenin: Evidence of inhibition of Wnt/β-catenin signaling as an important antitumor mechanism of microtubule-targeting agents

Anuradha Kumari et al.

Summary: The study demonstrates that microtubule-targeting agents inhibit the signaling of beta-catenin in oral squamous cell carcinoma, leading to a decrease in cancer malignancy. Additionally, the combined use of these agents with Wnt/beta-catenin signaling antagonists shows promise as a strategy for cancer chemotherapy.

FASEB JOURNAL (2021)

Review Cell Biology

Microtubule-targeting agents and their impact on cancer treatment

Vladimir Cermak et al.

EUROPEAN JOURNAL OF CELL BIOLOGY (2020)

Article Pharmacology & Pharmacy

C12, a combretastatin-A4 analog, exerts anticancer activity by targeting microtubules

Anuradha Kumari et al.

BIOCHEMICAL PHARMACOLOGY (2019)

Article Biochemical Research Methods

Quantitative determination of major alkaloids in Cinchona bark by Supercritical Fluid Chromatography

Adele Murauer et al.

JOURNAL OF CHROMATOGRAPHY A (2018)

Review Pharmacology & Pharmacy

Microtubule destabilising agents: far more than just antimitotic anticancer drugs

Darcy Bates et al.

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2017)

Article Chemistry, Multidisciplinary

Structural Basis of cis- and trans-Combretastatin Binding to Tubulin

Roberto Gaspari et al.

Article Chemistry, Multidisciplinary

Metal-free synthesis of N-fused heterocyclic iodides via C-H functionalization mediated by tert-butylhydroperoxide

Krishna K. Sharma et al.

CHEMICAL COMMUNICATIONS (2015)

Review Oncology

Targeting Microtubules by Natural Agents for Cancer Therapy

Eiman Mukhtar et al.

MOLECULAR CANCER THERAPEUTICS (2014)

Article Biochemistry & Molecular Biology

Dynein Light Chain 1 (LC8) Association Enhances Microtubule Stability and Promotes Microtubule Bundling

Jayant Asthana et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2012)

Article Chemistry, Organic

A divergent synthesis of substituted 2-aminoimidazoles from 2-aminopyrimidines

Denis S. Ermolat'ev et al.

JOURNAL OF ORGANIC CHEMISTRY (2008)

Article Biochemical Research Methods

Sulforhodamine B colorimetric assay for cytotoxicity screening

Vanicha Vichai et al.

NATURE PROTOCOLS (2006)

Review Chemistry, Medicinal

Medicinal chemistry of combretastatin A4: Present and future directions

GC Tron et al.

JOURNAL OF MEDICINAL CHEMISTRY (2006)

Article Multidisciplinary Sciences

Kinetic suppression of microtubule dynamic instability by griseofulvin: Implications for its possible use in the treatment of cancer

D Panda et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)

Article Chemistry, Medicinal

Synthesis and cytotoxic evaluation of combretafurazans

GC Tron et al.

JOURNAL OF MEDICINAL CHEMISTRY (2005)

Review Oncology

Microtubules as a target for anticancer drugs

MA Jordan et al.

NATURE REVIEWS CANCER (2004)

Article Chemistry, Medicinal

Synthesis and biological evaluation of 4-arylcoumarin analogues of combretastatins

C Bailly et al.

JOURNAL OF MEDICINAL CHEMISTRY (2003)